Compound
1 tablet contains 1 mg benzoxonium chloride and 1 mg lidocaine hydrochloride .
Additionally: microcrystalline cellulose; sorbitol ; sodium saccharinate; macrogol 6000 ; corn starch; sodium chloride; lemon acid; orange flavor; Magnesium stearate.
100 ml spray includes: 0.2% benzoxonium chloride and 0.15% lidocaine hydrochloride .
Additionally: 0.0025% menthol, 10% ethanol (96%); 0.0581% hydrochloric acid (0.1 N); 15% glycerin ; 0.01% peppermint oil; up to 100% purified water.
Pharmacodynamics and pharmacokinetics
Theraflu LAR is a therapeutic agent from the group of antiseptics that also have local anesthetic activity, which are intended for use in ENT practice .
Quaternary ammonium salt - benzoxonium chloride the cationic structure it contains , is characterized by membranotropic efficiency and exhibits pronounced antibacterial (antimicrobial) activity towards mainly gram-positive microorganisms (it has a lesser effect on gram-negative strains of bacteria ). Benzoxonium also has antifungal and antiviral effects aimed at suppressing membrane viruses (including herpes , influenza and parainfluenza ).
The anesthetic lidocaine, when used topically for the treatment of ENT organs, reduces or completely eliminates painful sensations in the throat noted when swallowing.
The absorption of benzoxonium is practically zero. This drug is not detected in human plasma, and does not accumulate in tissues. Approximately 1% of the administered dose of benzoxonium is determined in the urine.
Lidocaine absorption when taken orally occurs in the oral cavity through its mucous membrane. Metabolic transformations are carried out in the liver during the “first pass”. The bioavailability of lidocaine with this method of administration is approximately 35%. The products of its metabolism are excreted in the urine; less than 10% of the drug is excreted in unchanged form.
TheraFlu LAR spray against viruses and sore throat, spray 30ml
A country
Italy
The country of production may vary depending on the batch of goods. Please check with the operator for detailed information when confirming your order.
Active substance
Benzoxonium chloride + Lidocaine
Description
TheraFlu LAR spray is a spray against viruses and sore throat, which has 5 actions at once*: • Antiseptic • Local anesthetic • Antibacterial • Antiviral • Antifungal For adults, during each procedure, 4 sprays (approximately 0.5 ml), multiplicity - 3 -6 times a day.
Children (starting from 4 years old) - no more than 2-3 sprays during each procedure, frequency - 3-6 times a day*. * Antiseptic, local anesthetic, antibacterial (Gram (+), Gram (-)), antifungal, antiviral. Instructions for medical use, RU LS-001853 dated 08/05/2011
Compound
(per 100 ml): Active ingredients: benzoxonium chloride 200 mg (0.2%), lidocaine hydrochloride 150 mg (0.15%). Excipients: ethanol 96% (v/v) 10 g (10%), glycerol 15000 mg (15%), hydrochloric acid 0.1 M 58.1 mg (0.0581%), peppermint leaf oil 10 mg (0.01%), levomenthol 2.5 mg (0.0025%), purified water up to 100 ml (100%)
Product description
Transparent colorless solution.
pharmachologic effect
Benzoxonium chloride is a quaternary ammonium salt (N - benzyl - N - dodecyl - N,N - di (2 - hydroxyethyl) ammonium chloride), due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect against gram-positive and, to a lesser extent, gram-negative microorganisms. It also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses). Lidocaine is a local anesthetic that, during inflammatory processes, reduces pain in the throat when swallowing. Benzoxonium chloride is practically not absorbed. Approximately 1% of the administered dose is found in the urine; the concentration of the substance in the blood is practically undetectable. No accumulation of the substance was detected in body tissues. Lidocaine is absorbed orally and through the oral mucosa. Metabolized during the “first” passage through the liver; when administered orally, the bioavailability is approximately 35%. Metabolites are excreted in the urine, less than 10% of the substance is excreted unchanged.
Indications for use
Infections of the oral cavity and pharynx, accompanied by sore throat: pharyngitis, laryngitis, catarrhal tonsillitis, stomatitis, ulcerative gingivitis. As an aid – chronic tonsillitis.
Contraindications
Hypersensitivity to the components included in the drug or ammonia compounds, children (up to 4 years), pregnancy, breastfeeding.
Use during pregnancy and lactation
The effect of the drug on reproductive function and fetal development was not detected in the experiment. Clinical experience with the drug in pregnant women is very limited, and therefore the drug should not be used during pregnancy. There is no clinical data on the penetration of the active component into breast milk. However, the drug is not recommended for use during breastfeeding.
Directions for use and doses
Locally. Holding the can vertically, spray it in the mouth. Adults: during each procedure, 4 sprays are carried out (approximately 0.5 ml), frequency 3-6 times a day. Children (starting from 4 years old) - no more than 2-3 sprays during each procedure, frequency - 3-6 times a day. The duration of treatment should not exceed 5 days. If there is no relief from symptoms of the disease within 5 days after starting to take the drug, you should consult a doctor.
Side effect
Classification of the incidence of adverse reactions: very often - more than 1/10 of prescriptions (≥ 10%); often - more than 1/100, but less than 1/10 prescriptions (≥ 1%, but ≤ 10%); infrequently - more than 1/1000, but less than 1/100 prescriptions (≥ 0.1%, but ≤ 1%); rarely - more than 1/10000, but less than 1/1000 prescriptions (≥ 0.01%, but ≤ 0.1%); very rarely - less than 1/10,000 prescriptions (≤ 0.01%). Local reactions: Uncommon: temporary irritation. Allergic reactions: Rarely: allergic reactions. Isolated cases of urticaria, swelling of the face and larynx have been reported. When using the drug for more than 2 weeks, a reversible brown discoloration of the tongue or teeth may occur.
Overdose
Accidental ingestion of large doses of the drug, like other ammonia compounds, can lead to nausea or vomiting. In case of poisoning, you should drink milk or eat egg whites beaten in water. The lidocaine content in TheraFlu LAR is insignificant and it cannot cause serious overdose symptoms.
Interaction with other drugs
The effectiveness of benzoxonium chloride is reduced when taking anionic agents such as toothpaste. Alcohol increases the absorption of benzoxonium chloride (drinking alcohol should be avoided during therapy).
special instructions
TheraFlu LAR spray is intended for topical use only.
Release form
Spray for topical use. 30 ml of the drug in a high-density polyethylene bottle with a spray device and a protective cap made of low-density polyethylene. The bottle, complete with a polypropylene spray nozzle and instructions for use, is placed in a cardboard pack. Secondary packaging is allowed to have a first-opening control.
Storage conditions
At a temperature not exceeding 30 C. Keep out of the reach of children.
Best before date
3 years. Do not use after expiration date
Indications for use
Theraflu LAR is indicated for the treatment of diseases of infectious and inflammatory etiology occurring in the pharynx and oral cavity, including:
- ulcerative gingivitis ;
- pharyngitis;
- catarrhal tonsillitis ;
- laryngitis;
- stomatitis;
- chronic tonsillitis (as a means of auxiliary therapy).
Side effects
Occasionally, when using Theraflu LAR, local reactions are observed, manifested by irritation , which are temporary.
In isolated cases, allergic manifestations , expressed by the occurrence of urticaria , as well as swelling of the larynx and/or face.
If the drug was used for more than 14 days, brown staining of the teeth and/or tongue
TheraFlu LAR tablets against viruses and sore throat, tablets N16
A country
India
Country of manufacture may vary depending on the batch of goods. Please check with the operator for detailed information when confirming your order.
Active substance
Benzoxonium chloride + Lidocaine
Description
TERAFLU LAR WITH ORANGE FLAVOR in the form of tablets - these are 5 actions at once for a sore throat *: • Antiseptic • Local anesthetic • Antibacterial • Antiviral • Antifungal TheraFlu®Lar, thanks to the complex composition of antiseptic and anesthetic, will help relieve pain by affecting the cause (bacteria, viruses ) and consequence (symptoms). Active ingredients: benzoxonium chloride 1 mg, lidocaine hydrochloride 1 mg. * Antiseptic, local anesthetic, antibacterial (Gram (+), Gram (-)), antifungal, antiviral. Instructions for medical use, RU LS-002042 dated June 17, 2011
Compound
Active ingredients: benzoxonium chloride 1 mg, lidocaine hydrochloride 1 mg; Excipients: sorbitol 1000 mg, microcrystalline cellulose 20 mg, macrogol 6000 25 mg, corn starch 55 mg, sodium saccharinate 4 mg, sodium chloride 10 mg, citric acid 5 mg, magnesium stearate 1 mg, orange flavor 40 mg. One tablet contains 1 g of the sweetener sorbitol, which corresponds to approximately 17 kJ (4 kcal).
Product description
Round, biconvex tablets with the Zyma logo (two triangles located opposite each other with some offset) on one side and the OR code on the reverse side, white with a yellowish tint, with an orange odor.
pharmachologic effect
Benzoxonium chloride is a quaternary ammonium salt (N-benzyl N-dodecyl N, N-di (2-hydroxyethyl) ammonium chloride), due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect against gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses). Lidocaine is a local anesthetic that, during inflammatory processes, reduces pain in the throat when swallowing. Benzoxonium chloride is practically not absorbed. In humans, approximately 1% of the administered dose is found in the urine; the concentration of the substance in the blood is not detected. No accumulation of the substance was detected in body tissues. Lidocaine is absorbed orally and through the oral mucosa. Metabolized during the “first” passage through the liver; when administered orally, its bioavailability is approximately 35%. Metabolites are excreted in the urine, less than 10% of the substance is excreted unchanged.
Indications for use
Infections of the oral cavity and pharynx: pharyngitis, laryngitis, catarrhal tonsillitis, stomatitis, ulcerative gingivitis. As an aid – chronic tonsillitis.
Contraindications
Hypersensitivity to lidocaine or ammonia compounds. The use of the drug is not recommended for children under 4 years of age, in the first trimester of pregnancy and during breastfeeding.
Use during pregnancy and lactation
The effect of the drug on reproductive function and fetal development was not detected in the experiment. There have been no controlled studies in pregnant women, and therefore TheraFlu LAR should not be used during pregnancy, especially in the first trimester. There is no clinical data on the penetration of the active component into breast milk. However, the drug is not recommended for use during breastfeeding.
Directions for use and doses
Inside. Single dose – 1 tablet every 2-3 hours. For severe symptoms of the disease, 1 tablet every 1-2 hours. The tablet should dissolve slowly in the mouth. The daily dose should not exceed 10 tablets. Children: TheraFlu LAR can be used in children starting from 4 years old, 1 tablet every 2-3 hours. The daily dose should not exceed 6 tablets
Side effect
Sometimes when using TheraFlu LAR, local irritation is observed, which is temporary. Allergic reactions are rare. When using the drug for more than 2 weeks, a reversible brown coloration of the tongue or teeth may occur.
Overdose
Accidental ingestion of large doses of TheraFlu LAR, like other ammonia compounds, may cause nausea or vomiting. In case of overdose, it is recommended to drink milk or eat egg whites beaten in water. The lidocaine content in TheraFlu LAR is insignificant and cannot cause serious overdose symptoms.
Interaction with other drugs
The effectiveness of benzoxonium chloride is reduced by concomitant use of anionic agents, such as toothpaste. Alcohol increases the absorption of benzoxonium chloride (drinking alcohol should be avoided during therapy).
Release form
8 tablets are packed in a blister made of a combined material PVC / PE / PVDC / aluminum foil. Two blisters are placed together with instructions for use in a cardboard pack
Storage conditions
Store in a dry place at temperatures below 30 C. Keep out of the reach of children.
Best before date
3 years. Do not use the drug after the expiration date indicated on the package.
Instructions for use Theraflu LAR
For adult patients, the instructions for using Theraflu LAR tablets recommend dissolving 1 tablet of the drug every 2-3 hours. In case of severe symptoms of the disease, it is allowed to dissolve 1 tablet of Theraflu LAR every 60-120 minutes, but taking into account the maximum possible daily dosage of 10 tablets.
The daily dose of the drug for children (after 4 years) is a maximum of 6 tablets, maintaining the recommended dosage frequency - 1 tablet every 2-3 hours.
The tablets should be dissolved slowly until they are completely dissolved.
Theraflu LAR spray instructions for use recommend using patients over 4 years of age 3-6 times every 24 hours. Adult patients can perform up to 4 sprays once, children over 4 years old - no more than 2-3 sprays.
Theraflu LAR spray must be sprayed into the oral cavity while holding the canister with the drug strictly vertically.
If no relief of symptoms is observed within 5 days of using any of the dosage forms of Theraflu LAR, you should stop the treatment and consult your doctor.
Use of the drug Theraflu Lar
The drug is used for therapy in adults and children over 4 years of age. Tablet form. Adults : single dose - 1 tablet every 2-3 hours. For severe symptoms of the disease - 1 tablet every 1-2 hours. The tablet should be slowly dissolved in the mouth. The daily dose should not exceed 10 tablets. Children over 4 years of age : 1 tablet every 2–3 hours. The daily dose should not exceed 6 tablets. Aphthous ulcers : Allow the tablet to dissolve slowly in direct contact with the ulcer. The duration of treatment depends on the clinical course of the disease. Spray . Adults: with each procedure, 4 injections are carried out, the frequency is 3-6 times a day. Children aged 4 years and older : no more than 2-3 injections during each procedure, frequency - 3-6 times a day. Holding the can vertically, spray it in the mouth and throat. Before the first use, you need to apply a few pressures until the spray appears. The duration of treatment depends on the course of the disease.
Overdose
In case of accidental or intentional oral administration of excessive dosages of Theraflu LAR (any of its dosage forms), nausea / vomiting . The mass fraction of lidocaine in the drug is insufficient to cause any negative symptoms.
As a treatment for the above conditions, it is recommended to eat egg whites , previously beaten in water, or drink milk .
Theraflu lar tablets against viruses and sore throat, tablets, 16 pcs.
pharmachologic effect
Antiseptic drug for local use in ENT practice.
It is a quaternary ammonium salt: N-benzyl N-dodecyl N, N-di(2-hydroxyethyl) ammonium chloride. Due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect on gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses). Lidocaine is a local anesthetic that, during inflammatory processes, reduces pain in the throat when swallowing.
Composition and release form Theraflu lar tablets against viruses and sore throat, tablets, 16 pcs.
Active substance: benzoxonium chloride 1 mg; lidocaine hydrochloride 1 mg;
Excipients: sorbitol - 1 g (corresponds to approximately 17 kJ/4 kcal), microcrystalline cellulose - 20 mg, macrogol 6000 - 25 mg, corn starch - 55 mg, sodium saccharinate - 4 mg, sodium chloride - 10 mg, citric acid - 5 mg, magnesium stearate - 1 mg, orange flavor - 40 mg.
Description of the dosage form
Lozenges are white with a yellowish tint, round, biconvex, with the Zyma logo (two triangles located opposite each other with some offset) on one side and the code “OR” on the reverse side, with an orange smell.
Characteristic
Antiseptic + local anesthetic
Directions for use and doses
Adults are prescribed 1 tablet. for resorption every 2-3 hours or as a spray, 4 sprays (approximately 0.5 ml) 3-6 times/day. For severe symptoms of the disease, 1 tablet can be used. every 1-2 hours. The daily dose should not exceed 10 tablets.
Children aged 4 years and older are prescribed 1 tablet. for resorption every 2-3 hours or in the form of a spray, 2-3 sprays 3-6 times/day. The daily dose should not exceed 6 tablets.
The duration of treatment is no more than 5 days. If there is no relief of symptoms within 5 days of therapy, the patient should consult a doctor.
The tablet should be slowly dissolved in the mouth until completely dissolved. The solution in the form of a spray is sprayed into the oral cavity, holding the can vertically.
Pharmacodynamics
Benzoxonium chloride is a quaternary ammonium salt: N-benzyl N-dodecyl N, N-di(2-hydroxyethyl)-ammonium chloride. Due to its cationic structure, it has membranotropic activity and has a pronounced antibacterial effect on gram-positive and, to a lesser extent, gram-negative microorganisms. Benzoxonium also has antifungal and antiviral activity against membrane viruses (including influenza, parainfluenza and herpes viruses). Lidocaine is a local anesthetic that, during inflammatory processes, reduces pain in the throat when swallowing.
Pharmacokinetics
Benzoxonium chloride is practically not absorbed. In humans, the active substance is not detected in the blood. No accumulation of the active substance was detected in body tissues. About 1% of the received dose of benzoxonium chloride is found in the urine.
Lidocaine is absorbed when taken orally and through the oral mucosa. Metabolized during the “first pass” through the liver. When administered orally, bioavailability is about 35%. Metabolites of lidocaine are excreted in the urine, less than 10% of the active substance is excreted unchanged.
Indications for use Theraflu lar tablets against viruses and sore throat, tablets, 16 pcs.
Infectious and inflammatory diseases of the oral cavity and pharynx: pharyngitis; laryngitis; catarrhal tonsillitis; stomatitis; ulcerative gingivitis; chronic tonsillitis (as an adjuvant).
Contraindications
- Pregnancy;
- lactation period (breastfeeding);
- children under 4 years of age;
- hypersensitivity to the components of the drug;
- increased sensitivity to ammonia compounds.
Effect on the body
Antiseptic + local anesthetic
Use of Theraflu lar tablets against viruses and sore throat, tablets, 16 pcs during pregnancy and breastfeeding
The drug is contraindicated for use in the first trimester of pregnancy and during lactation (breastfeeding).
Adequate and strictly controlled clinical studies of the safety of the drug during pregnancy have not been conducted. The use of the drug in the II and III trimesters is not recommended.
There is no clinical data on the release of active substances into breast milk. However, the drug is not recommended for use during breastfeeding.
In experimental studies, no effect of the drug on reproductive function and fetal development was found.
special instructions
While using the drug, you should avoid drinking alcohol.
Overdose
Symptoms: accidental ingestion in high doses may result in nausea and vomiting. The content of lidocaine in the drug is insignificant and cannot cause serious overdose symptoms.
Treatment: It is recommended to drink milk or eat egg whites beaten in water.
Side effects of Theraflu lar tablets against viruses and sore throat, tablets, 16 pcs.
Possible: local irritation; when used for more than 2 weeks - reversible brown coloration of the tongue and teeth.
Rarely: allergic reactions.
Drug interactions
The effectiveness of benzoxonium chloride decreases with the simultaneous use of anionic agents, such as toothpaste.
Ethanol increases the absorption of benzoxonium chloride.
Analogs
Level 4 ATX code matches:
Falimint
Suprima-ENT
Ingalipt-N
Strepsils Plus
Strepsils
Ingalipt
Hexoral Tabs
Lisak
Efizol
Angilex
Kameton
Anzibel
Agisept
Yox
Lugol's solution with glycerin
Lugol
Laripront
Stopangin 2A
Stopangin
Septolete Neo
- Anti-angin;
- Hexalize;
- Agisept;
- Voqara;
- Gorpils;
- Hexasprey;
- Septolete;
- Ingalipt;
- Neo-Angin;
- Kameton;
- Rinza Lorsept;
- Tonsipret;
- Faringosept;
- Strepsils;
- Falimint.
Reviews
Patients who use TheraFlu LAR tablets or spray for the treatment of various painful conditions of the pharynx and oral cavity that have an infectious-inflammatory etiology generally characterize this drug on the positive side. In most cases, the drug copes well with pain in these organs and prevents the further development of bacterial infection . Naturally, treatment with one antiseptic may often be insufficient and require the addition of other medications from various pharmaceutical groups to the therapy.
Price, where to buy
The price of Theraflu Lar tablets No. 16 averages 200 rubles.
The average price of a 30 ml spray is 250 rubles.
- Online pharmacies in RussiaRussia
- Online pharmacies in KazakhstanKazakhstan
ZdravCity
- TheraFlu LAR spray for local use.
approx. fl. 30ml (with dispenser) Doppel Pharmaceutical S.r.L. RUB 321 order - TheraFlu LAR against viruses and sore throat with menthol flavor lozenges 20 pcsNovartis Urunleri
RUB 266 order
Pharmacy Dialogue
- TheraFlu LAR menthol against viruses and sore throat, tablets N20Novartis
RUB 249 order
- TheraFlu LAR tablets against viruses and sore throat, tablets N16Novartis
RUB 196 order
- TheraFlu LAR spray against viruses and sore throat, spray 30mlNovartis
RUB 311 order
show more
Theraflu lar menthol against viruses and sore throat, tablets, 20 pcs.
pharmachologic effect
Combined for local use, contains an antiseptic and local anesthetic.
Cetylpyridinium chloride is an antiseptic from the group of quaternary ammonium compounds, has bactericidal activity against gram-positive and, to a lesser extent, gram-negative bacteria. Changes the permeability of the cytoplasmic membrane of bacteria, disrupts the internal oxidative mechanisms of bacterial respiration, which leads to their death. Cetylpyridinium chloride has antifungal and antiviral activity against enveloped viruses.
Lidocaine hydrochloride is a local anesthetic from the amide group that relieves pain in the throat when swallowing during inflammatory processes. Lidocaine disrupts the permeability of the cell membrane to sodium ions, which leads to anesthesia as a result of blocking the conduction of nerve impulses.
Composition and release form Theraflu lar menthol against viruses and sore throat, tablets, 20 pcs.
Active substance: cetylpyridinium chloride 2 mg; lidocaine hydrochloride 1 mg;
Excipients: black-leaved peppermint leaf oil - 0.5 mg, Schimmel peppermint leaf oil - 0.5 mg, levomenthol - 6 mg, acesulfame potassium - 6 mg, corn starch - 55 mg, citric acid monohydrate - 5 mg, macrogol 6000 - 25 mg , microcrystalline cellulose (Avicel PH-105) - 20 mg, magnesium stearate - 2 mg, sorbitol (Karion 3140) - 1107 mg.
Description of the dosage form
Lozenges (menthol) are white, rectangular, with beveled edges, with a menthol scent.
Characteristic
Antiseptic + local anesthetic
Directions for use and doses
The tablet should be dissolved slowly in the mouth.
The tablet should not be chewed or swallowed. TheraFlu® LAR Menthol should not be taken during or immediately before meals.
Adults and children over 12 years old: 1 tablet. every 1-2 hours for acute inflammation and severe pain. For milder conditions - 1 tablet. every 2-3 hours. The maximum daily dose is no more than 6 tablets.
Children from 6 to 12 years old: 1 tablet. every 3-4 hours as needed, maximum daily dose - no more than 3 tablets.
TheraFlu® LAR Menthol tablets should not be used for more than 5 days in a row. If symptoms persist or are accompanied by high fever, dizziness or vomiting, you should stop taking the drug and consult your doctor.
Pharmacokinetics
Cetylpyridinium chloride is practically not absorbed through the oral mucosa.
Lidocaine hydrochloride is poorly absorbed through the oral mucosa. When taken orally, it is absorbed and undergoes first-pass metabolism through the liver. When taken orally, its bioavailability is about 35%. Metabolites are excreted in the urine, less than 10% of the substance is excreted unchanged.
Indications for use Theraflu lar menthol against viruses and sore throat, tablets, 20 pcs.
Infectious and inflammatory diseases of the mouth and throat: pharyngitis; laryngitis; catarrhal tonsillitis; stomatitis; ulcerative gingivitis; tonsillitis (as an adjuvant).
Contraindications
- I trimester of pregnancy;
- breastfeeding period;
- children under 6 years of age;
- sucrase/isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption;
- hypersensitivity to the components of the drug.
With caution: open wounds of the oral mucosa.
Effect on the body
Antiseptic + local anesthetic
Application of Theraflu lar menthol against viruses and sore throat, tablets, 20 pcs during pregnancy and breastfeeding
The use of Theraflu® LAR Menthol is contraindicated in the first trimester of pregnancy, since the drug penetrates the placental barrier. Use in the II-III trimesters of pregnancy is possible under the supervision of a physician, if the expected benefit to the mother outweighs the potential risk to the fetus.
The drug is excreted in breast milk, so it is not recommended for use during breastfeeding.
special instructions
Open wounds of the oral mucosa.
Overdose
Symptoms: if you accidentally take the drug (as well as other ammonium compounds) in high doses, nausea and vomiting are possible. The content of lidocaine in the drug is insignificant and cannot cause serious overdose symptoms.
Treatment: stop taking the drug immediately; It is recommended to drink milk or eat egg whites beaten in water.
Side effects of Theraflu lar menthol against viruses and sore throat, tablets, 20 pcs.
Determination of the frequency of adverse reactions: very often (≥10%); common (≥1% but ≤10%), uncommon (≥0.1% but ≤1%), rare (≥0.01% but ≤0.1%), very rare (≤0.01%).
From the digestive system: rarely - nausea; very rarely - diarrhea.
From the skin and subcutaneous tissues: very rarely - skin rash, itching.
Local reactions: rarely - local irritation of the mucous membrane of the mouth and throat.
Drug interactions
No drug interactions have been identified with Theraflu® LAR Menthol.
